Physicians who set policy received millions from pharma companies, says report
Nearly nine out of 10 physicians and researchers who helped develop a leading set of cancer care guidelines in the United States reported financial ties to the pharmaceutical and medical device industries, according to a new study by researchers at the UNC-Chapel Hill Lineberger Comprehensive Cancer Center.
The National Comprehensive Cancer Network has 125 panelists who set guidelines for lung, breast, prostate and colorectal cancer treatments. Of those, 108 received some form of industry funding....